Anixa Biosciences Inc

NASDAQ:ANIX

4.30

-0.08 (-1.83%)

4:18:48 PM EDT: $4.42 +0.12 (+2.79%)

Products

Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trial

Published: 08/30/2021 12:36 GMT

Anixa Biosciences Inc (ANIX) - Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer Car-t Immunotherapy.
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer Car-t Immunotherapy.
Anixa Biosciences Inc - Robert Wenham, Chair of Gynecological Oncology at Moffitt Will Lead Clinical Trial.